Results 31 to 40 of about 445,193 (314)

Effect of metformin therapy on 2-h post-glucose insulin levels in patients of polycystic ovarian syndrome

Journal of Human Reproductive Sciences, 2010
Aims : To evaluate if 2-h post glucose insulin level is an effective tool to monitor insulin resistance in response to metformin therapy, in infertile women with polycystic ovarian syndrome (PCOS).
Pikee Saxena, Anupam Prakash, Aruna Nigam   +2 more
doaj   +1 more source

Effectiveness and clinical benefits of new anti-diabetic drugs: A real life experience

Open Medicine, 2022
We evaluated the clinical impact, in daily clinical practice, of sodium-glucose co-transporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP1RA) therapies in patients with type 2 diabetes.
Piazzolla Giuseppina, Vozza Alfredo, Volpe Sara, Bergamasco Alessandro, Triggiani Vincenzo, Lisco Giuseppe, Falconieri Michela, Tortorella Cosimo, Solfrizzi Vincenzo, Sabbà Carlo   +9 more
doaj   +1 more source

A comparison of meal tolerance test and oral glucose tolerance test for predicting insulin therapy in patients with gestational diabetes

Food & Nutrition Research, 2021
Aims: To identify factors predicting a need for insulin therapy in gestational diabetes mellitus (GDM) by comparing plasma glucose (PG) levels in a 75-g oral glucose tolerance test (75-g OGTT) with those in a 500-kcal meal tolerance test (MTT) containing
Mai Hijikata, Mariko Higa, Takamasa Ichijo, Takahisa Hirose   +3 more
doaj   +1 more source

Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of cortisol : a pilot study [PDF]

, 2013
Background: Incidental adrenal masses are commonly detected during imaging for other pathologies. 10% of the elderly population has an ‘adrenal incidentaloma’, up to 20% of these show low-grade autonomous cortisol secretion and 60% of patients with ...
Rita Chadarevian, Eastell, R. (Richard), Richard J Ross, Richard Eastell (153287), Chadarevian, Rita, Debono, M., Newell-Price, John, Rita Chadarevian (399995), Richard J. Ross (399996), Richard Eastell, Randeva, Harpal S., Chadarevian, R., John Newell-Price (399997), Newell-Price, J., Ross, R.J., Miguel Debono (399994), Ross, Richard J. M., Miguel Debono, John Newell-Price, Eastell, R.   +19 more
core   +1 more source

Adherence to insulin therapy and associated factors among patients with diabetes mellitus in public hospitals of Central Zone of Tigray, Ethiopia, 2018: a cross-sectional study

The Pan African Medical Journal, 2019
INTRODUCTION: Adherence to insulin therapy is a critical factor for adequate control of diabetes mellitus. Despite the multiple well-known benefits of adherence to insulin therapy, poor adherence remains to be a common cause of diabetes mellitus-related ...
Teklewoini Mariye, Alem Girmay, Tsyion Birhanu, Hagos Tasew, Girmay Teklay, Zeray Baraki, Hadgu Gerensea, Tewolde Teklu, Gebrewahed Bezabeh   +8 more
doaj   +1 more source

Diabetic macroangiopathy and self-monitoring of glucose

Медицинский совет, 2014
Diabetic macroangiopathy is a general term for atherosclerotic vascular diseases of large- and medium-caliber arteries in diabetes mellitus (DM). Macrovascular complications of diabetes leading to cardiovascular diseases (CVD) are the major cause of ...
OS Fedorova
doaj   +1 more source

Wolcott-Rallison Syndrome, a Rare Cause of Permanent Diabetes Mellitus in Infants—Case Report

Pediatric Reports, 2023
Wolcott-Rallison syndrome is a rare cause of permanent neonatal diabetes mellitus caused by mutations in the eukaryotic translation initiation factor 2 alpha kinase 3 gene (EIF2AK3).
Alexandru-Ștefan Niculae, Claudia Bolba, Alina Grama, Alexandra Mariş, Laura Bodea, Simona Căinap, Alexandra Mititelu, Otilia Fufezan, Tudor Lucian Pop   +8 more
doaj   +1 more source

Improved Cardiovascular and Cardiometabolic Risk in Patients With Type 1 Diabetes and Autoimmune Polyglandular Syndrome Switched From Glargine to Degludec Due to Hypoglycaemic Variability

Frontiers in Endocrinology, 2018
Background: Cardiovascular disease is a frequent complication of type 1 diabetes (T1D). We evaluated the effectiveness of switching from glargine to degludec in reducing the cardiovascular risk factors, the Framingham risk score (FRS) and visceral ...
Valentina Guarnotta, Giulia Di Bella, Giuseppe Pillitteri, Alessandro Ciresi, Carla Giordano   +4 more
doaj   +1 more source

Individual Approach to the Treatment of Diabetes Mellitus Type 2: When, to Whom and What are the Alternative Options Besides Metformin

Mìžnarodnij Endokrinologìčnij Žurnal, 2013
The article discusses the question of strategy choice for hypoglycemic treatment in patients with diabetes type 2 who have contraindications to metformin or its intolerance.
V.I. Pankiv
doaj   +1 more source

Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 study

Archives of Medical Science, 2020
Introduction Apolipoprotein complement is a critical determinant of lipoprotein function and metabolism. The relation between exogenous insulin and apolipoproteins (apos) in newly diagnosed type 1 diabetes mellitus (T1DM) has not yet been studied ...
Aleksandra Cieluch, Aleksandra Uruska, Marcin Nowicki, Ewa Wysocka, Paweł Niedźwiecki, Agata Grzelka-Woźniak, Justyna Flotyńska, Dorota Zozulinska-Ziolkiewicz   +7 more
doaj   +1 more source